AboutValuesWhy OA.mg?OA.mg PremiumExploreDataContact
Chrome ExtensionScholarMindChatGPT Plugin
ϟ

Open Access Secukinumab Journals

A list of Open Access Secukinumab journals for you to publish your manuscript in

Secukinumab is monoclonal antibody against IL-17 used for treatment of psoriasis

Open access (OA) is a key part of making research shareable and reproducable. All journal articles published open access undergoe the same rigorous peer review process.

Hopefully this list of Secukinumab Open Access journals will make it easier for you to decide where to publish your Secukinumab manuscript.
The list below includes all high-impact factor Secukinumab journals as well as new up and comming journals where it might also be more affordable to publish.Instead of displaying the most commonly known Secukinumab journals, we have made an exhaustive list of open accesss Secukinumab journals. Use our different columns — number of papers, number of citations, and relevance — to find the best Secukinumab venue for your manuscript.

The DOAJ columns refers to the The Directory of Open Access Journals, a list of open access journals, maintained by Infrastructure Services for Open Access.
There are certain criteria a journal must meet to be indexed by DOAJ, and thus inclusion in the DOAJ index is seen by scholars as a mark of quality.


All the open access Secukinumab journals in this list are indexed in OA.mg.
If you spot any mistakes in this table of Secukinumab OA journals, don’t hesitate to send us an email.

Open Access Secukinumab Journals
NameISSNDOAJPublisherNo. of PapersCitationsRelevance▼Website
Page 1 of 0

Related lists of open access journals:

Open Access Infliximab JournalsOpen Access Ustekinumab JournalsOpen Access Adalimumab JournalsOpen Access Etanercept JournalsOpen Access Apremilast JournalsOpen Access TNF Inhibitor JournalsOpen Access Anakinra JournalsOpen Access Interleukin 17 JournalsOpen Access Tocilizumab JournalsOpen Access Rheumatoid Arthritis JournalsOpen Access Golimumab JournalsOpen Access Canakinumab Journals

Frequently Asked Questions

Where can I publish my Secukinumab paper?
You can publish your Secukinumab paper in the Open Access journals in this list
What is Open Access (OA)?
Open Access aims to provide immediate and unrestricted access to research articles while along you to also share it freely
What does “relevance” mean in the table?
In the table above, relevance is used to determine the level of association between a journal and the concept it is listed under, from 0-100.
How do you count total number of citations?
The citations represent the times that works have cited papers under this journal. In our case, we obtain this data from OpenAlex, an open catalog of scholarly papers. It's hard to say how accurate it is but it can give you a general idea on how prestigious the journal is. The more work that have cited it, the better.
Where can I find other lists like this one?
To search for more open journal lists under different topics, look on OA.mg
How can I publish my paper on OA.mg?
At the moment, we do not offer publishing services, that's why we made these lists, so you can find the right journal to publish your paper in. Our goal with OA.mg is to help disseminate research.
What is an APC?
In some cases, articles published in journals are made open access and freely available online, immediately upon publication. This is made usually made possible by an article-processing charge (APC) that covers the range of publishing services provided.
What are the different Open Access types?
The most common types are “Green Open Access”, “Gold Open Access” and “Hybrid Open Access”.
OA.mgAbout UsOur ValuesWhy OA.mg? OA.mg PremiumChrome ExtensionChatGPT PluginPublic RoadmapChangelogContact UsFeedback?
Privacy PolicyTerms of ServiceRefund Policy
ContentOA.mg CoverageTop ListsOpen Access JournalsTopicsBlog
ExploreGeographyEngineeringPoliSciGeologyPhilosophySociologyArtHistoryMathematicsPhysics
 PsychologyComputer ScienceBusinessEnvironmental ScienceChemistryMaterials ScienceMedicineBiologyEconomics
OA.mg is built in Stockholm, London, and Seoul. We work hand in hand with the scientific community to advance the cause of Open Access. Feedback makes us better.